Immunotherapy for cancer in the central nervous system: Current and future directions

被引：46

作者：

Binder, David C. ^{[1
,2
]}

Davis, Andrew A. ^{[3
]}

Wainwright, Derek A. ^{[4
]}

机构：

[1] Univ Chicago, Commitee Canc Biol, Chicago, IL 60637 USA

[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA

[3] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA

[4] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA

来源：

ONCOIMMUNOLOGY | 2016年 / 5卷 / 02期

关键词：

Brain metastases; glioblastoma; glioma; IDO; T cell therapy; vaccination; NEWLY-DIAGNOSED GLIOBLASTOMA; GROWTH-FACTOR RECEPTOR; DENDRITIC CELL VACCINATION; FIXED TUMOR VACCINE; LONG-TERM SURVIVAL; REGULATORY T-CELLS; PHASE I/IIA TRIAL; HIGH-GRADE GLIOMA; ANTITUMOR IMMUNITY; CTLA-4; BLOCKADE;

D O I：

10.1080/2162402X.2015.1082027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and still remains incurable. Although immunotherapeutic vaccination against GBM has demonstrated immune-stimulating activity with some promising survival benefits, tumor relapse is common, highlighting the need for additional and/or combinatorial approaches. Recently, antibodies targeting immune checkpoints were demonstrated to generate impressive clinical responses against advanced melanoma and other malignancies, in addition to showing potential for enhancing vaccination and radiotherapy (RT). Here, we summarize the current knowledge of central nervous system (CNS) immunosuppression, evaluate past and current immunotherapeutic trials and discuss promising future immunotherapeutic directions to treat CNS-localized malignancies.

引用

页数：15

共 110 条

[1] HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors [J].

Ahmed, Nabil ;

Salsman, Vita S. ;

Kew, Yvonne ;

Shaffer, Donald ;

Powell, Suzanne ;

Zhang, Yi J. ;

Grossman, Robert G. ;

Heslop, Helen E. ;

Gottschalk, Stephen .

CLINICAL CANCER RESEARCH, 2010, 16 (02) :474-485

[2] α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial [J].

Akiyama, Yasuto ;

Oshita, Chie ;

Kume, Akiko ;

Iizuka, Akira ;

Miyata, Haruo ;

Komiyama, Masaru ;

Ashizawa, Tadashi ;

Yagoto, Mika ;

Abe, Yoshiaki ;

Mitsuya, Koichi ;

Watanabe, Reiko ;

Sugino, Takashi ;

Yamaguchi, Ken ;

Nakasu, Yoko .

BMC CANCER, 2012, 12

[3] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study [J].

Ardon, Hilko ;

Van Gool, Stefaan ;

Lopes, Isabel Spencer ;

Maes, Wim ;

Sciot, Raf ;

Wilms, Guido ;

Demaerel, Philippe ;

Bijttebier, Patricia ;

Claes, Laurence ;

Goffin, Jan ;

Van Calenbergh, Frank ;

De Vleeschouwer, Steven .

JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) :261-272

[4] Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions [J].

Avril, Tony ;

Saikali, Stephan ;

Vauleon, Elodie ;

Jary, Anne ;

Hamlat, Abderrahmane ;

De Tayrac, Marie ;

Mosser, Jean ;

Quillien, Veronique .

JOURNAL OF NEUROIMMUNOLOGY, 2010, 225 (1-2) :22-33

[5] Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice [J].

Bai, Ailin ;

Higham, Eileen ;

Eisen, Herman N. ;

Wittrup, K. Dane ;

Chen, Jianzhu .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) :13003-13008

[6] Restoring function in exhausted CD8 T cells during chronic viral infection [J].

Barber, DL ;

Wherry, EJ ;

Masopust, D ;

Zhu, BG ;

Allison, JP ;

Sharpe, AH ;

Freeman, GJ ;

Ahmed, R .

NATURE, 2006, 439 (7077) :682-687

[7] CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].

Basu, S ;

Binder, RJ ;

Ramalingam, T ;

Srivastava, PK .

IMMUNITY, 2001, 14 (03) :303-313

[8] Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model [J].

Belcaid, Zineb ;

Phallen, Jillian A. ;

Zeng, Jing ;

See, Alfred P. ;

Mathios, Dimitrios ;

Gottschalk, Chelsea ;

Nicholas, Sarah ;

Kellett, Meghan ;

Ruzevick, Jacob ;

Jackson, Christopher ;

Albesiano, Emilia ;

Durham, Nicholas M. ;

Ye, Xiaobu ;

Tran, Phuoc T. ;

Tyler, Betty ;

Wong, John W. ;

Brem, Henry ;

Pardoll, Drew M. ;

Drake, Charles G. ;

Lim, Michael .

PLOS ONE, 2014, 9 (07)

[9] Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma [J].

Berghoff, Anna Sophie ;

Kiesel, Barbara ;

Widhalm, Georg ;

Rajky, Orsolya ;

Ricken, Gerda ;

Woehrer, Adelheid ;

Dieckmann, Karin ;

Filipits, Martin ;

Brandstetter, Anita ;

Weller, Michael ;

Kurscheid, Sebastian ;

Hegi, Monika E. ;

Zielinski, Christoph C. ;

Marosi, Christine ;

Hainfellner, Johannes A. ;

Preusser, Matthias ;

Wick, Wolfgang .

NEURO-ONCOLOGY, 2015, 17 (08) :1064-1075

[10] High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies [J].

Binder, David C. ;

Schreiber, Hans .

ONCOIMMUNOLOGY, 2013, 2 (12) :1-3

← 1 2 3 4 5 6 7 8 9 10 →